Senores Pharmaceuticals Limited — Updates, 16-01-2026: General Updates
16-01-2026 | 05:58 pm
16-01-2026 | 05:58 pm
Senores Pharma acquired additional 56,63,804 equity shares of Apnar Pharma for ₹11.46 Cr, raising its stake to 75%. The remaining 25% acquisition is anticipated.
No comments yet. Be the first to comment!
